From hotel suites to virtual reality, museums turn to licensing deals as costs rise
Natural History Museum and British Museum among cultural institutions leveraging collections and exhibitionsThey are often free to visit but museums a...
Last updated: 2026-10-05 07:48:22 ET
Pulse AI Brief
Updated Oct 5, 2026 7:04 AM ET
The Natural History Museum and British Museum are aggressively licensing their collections and exhibitions to generate revenue, including partnerships for hotel suites, virtual reality experiences, and commercial ventures. The shift reflects rising operational costs and declining public funding forcing cultural institutions to embrace commercial models.
Museum licensing creates new revenue streams for cultural institutions while opening opportunities for hospitality, tech, and entertainment companies to access premium intellectual property. This trend could accelerate consolidation of museum partnerships and create new publicly traded opportunities in experiential licensing.
The commercialization of museums reflects broader pressure on public institutions to self-fund amid austerity. This model risks commodifying cultural heritage while potentially democratizing access through virtual offerings, creating tension between preservation and profitability.
Natural History Museum and British Museum among cultural institutions leveraging collections and exhibitionsThey are often free to visit but museums a...
Commercial vehicle enforcement operations across the U.S. and Canada resulted in hundreds of trucks and drivers being sidelined for licensing, equipme...
Brazil is trying to speed up mine approvals just as its Supreme Court weighs challenges that could undo parts of the country’s new environmental licensing system. The overhaul sets national... The post Brazil mine licence system faces court test ap...
Dangote Petroleum Refinery and Petrochemicals FZE has selected Honeywell International to supply technologies, licensing, engineering, catalysts, equi...
EU regulators are reportedly examining Binance’s use of a MiCA exemption to serve customers as ESMA seeks stronger enforcement powers.
Novo Nordisk on Tuesday struck its second licensing deal since receiving a poor reception from investors after presenting its long-term strategy.
Unlock the AI Macro Analyst to drill down into the data, explore hidden risks, and query the entire market briefing in real-time.
LOG IN / SUBSCRIBE